https://www.deccanherald.com/national/covaxin-show..

Zajednica

Gledati Koluti Događaji Blog Tržište Forum Moji proizvodi Moje stranice

Istražiti

Istražiti popularne objave Igre Filmovi Poslovi Ponude Sredstva

© 2025 Dostally

Oko • Imenik • Kontaktirajte nas • Programeri • Politika privatnosti • Uvjeti korištenja • Povrat novca

4 god

https://www.deccanherald.com/n....ational/covaxin-show

Covaxin shows robust safety, immunogenicity in 2-18-year-olds: Bharat Biotech reveals clinical trial data | Deccan Herald

www.deccanherald.com

Covaxin shows robust safety, immunogenicity in 2-18-year-olds: Bharat Biotech reveals clinical trial data | Deccan Herald

Bharat Biotech International Limited (BBIL) said that its Covid-19 vaccine has demonstrated “robust safety and immunogenicity” in trials for 2-18-year-olds. The Hyderabad-based vaccine maker said that neutralising antibodies in children were found to

Kao

Komentar

Najnoviji proizvodi Vidi sve